Aktie A3EWDE HEALWELL AI INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Healwell AI Inc. Börse Stuttgart

Aktien

A3EWDE

CA42249X1006

6H90

Realtime-Estimate Tradegate
Andere Börsenplätze
 17:58:04 17.06.2024 		% 5 Tage % 1. Jan.
1,868 EUR +3,78 % Intraday Chart für Healwell AI Inc. +19,21 % +267,35 %
13.06. Healwell AI erwirbt BioPharma Services für 11,9 Millionen Dollar und erweitert damit sein Angebot an klinischer Forschung MT
11.06. Healwell AI erwirbt VeroSource Solutions für 24,5 Millionen Dollar und fügt seine Cloud-basierte Plattform für die Interoperabilität von Gesundheitsdaten hinzu MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Healwell AI Agrees to Buy BioPharma Services For $11.9 Million to Expand Clinical Research Offerings
HEALWELL AI to Acquire BioPharma, One of Canada's Largest CROs, to Expand and AI-Enable Clinical Research Offerings
Healwell AI Inc. agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.
Healwell AI Agrees to Buy VeroSource Solutions for $24.5 Million to Add its Cloud-Based Health Data Interoperability Platform
HEALWELL AI to Acquire VeroSource Solutions and its Cloud-based Health Data Interoperability Platform to Help Large Enterprises Adopt AI-Powered Population Health Capabilities
Healwell AI Inc. agreed to acquire VeroSource Solutions Inc. for CAD 24.5 million on June 11, 2024.
Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema
HEALWELL AI Unit Partners With Takeda for Rare Disease Evidence Analysis
HEALWELL AI Brief: Subsidiary Pentavere Announcing Partnership with Takeda to "Support Rare Disease Real-World Evidence Analysis for Patients living with Hereditary Angioedema"
HEALWELL AI’s Pentavere Announces Partnership with Takeda to Support Rare Disease Real-World Evidence Analysis for Patients living with Hereditary Angioedema
HEALWELL AI Appoints Anthony Lam as its Chief Financial Officer
HEALWELL AI Brief: Lam will replace Scott Nirenberski who has been CFO since Sept 2020
HEALWELL AI Brief: Appointing Anthony Lam as New Chief Financial Officer
HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer
Healwell AI Inc. Announces Chief Financial Officer Changes
Healwell AI Closes Upsized $20 Million Bought-Deal Private Placement of Share Units
HEALWELL AI Closes Upsized $20 Million Bought Deal Offering
Healwell AI Inc. announced that it has received CAD 20.00025 million in funding
Healwell AI Subsidiary Partners With Sunnybrook Hospital to Show AI Platform Role in Cancer Staging
HEALWELL AI’s Pentavere Partners with Sunnybrook and Successfully Demonstrates its AI Powered Clinician Co-pilot System Can Improve Cancer Staging in Prestigious Peer-Reviewed Medical Journal
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EWDE Aktie
  4. A3EWDE Aktie
  5. Nachrichten Healwell AI Inc.
  6. Andere Sprachen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT